SCHEMBL770019

SCHEMBL770019

CC1CC12CN([C@H](C)c1ccccc1)CC2OC(=O)NC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
CYP2D6 P10635 2/20 0.35
CHRM2 P08172 3/20 0.34
CHRM4 P08173 3/20 0.34
CHRM5 P08912 3/20 0.34
CHRM1 P11229 3/20 0.34
CHRM3 P20309 3/20 0.34
CTSK P43235 3/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 2/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28219354 0.87 CTSK (0.42) CTSK
SCHEMBL28281004 0.75 CYP2D6 (0.44) CYP2D6CHRM4HTTCYP1A2CYP3A4
SCHEMBL8775423 0.71 CHRM2 (0.46) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL8775418 0.71 CHRM2 (0.46) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL869078 0.69 CYP2D6 (0.36) KMT2ACYP2D6MEN1LMNAGAA
SCHEMBL16909708 0.69 KMT2A (0.41) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL28417009 0.69 CHRM2 (0.41) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL28414486 0.69 CHRM2 (0.41) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL28417011 0.69 CHRM2 (0.41) KMT2ACYP2D6CHRM2CHRM4CHRM5
SCHEMBL28414488 0.69 CHRM2 (0.41) KMT2ACYP2D6CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120071459-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS GLAXOSMITHKLINE LLC 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071459-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS MCHR1, MCHR2, MC1R KMT2A 2648/4885CYP2D6 557/4885CHRM2 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.